Opioids Collections

Mallinckrodt Litigation Documents


Date Range: 1995-2019; bulk 2010-2015

Overview and Background

Founded in 1867 in St. Louis, Mo., Mallinckrodt Pharmaceuticals is a leading manufacturer of opioid painkillers. Its subsidiary, SpecGx, dominated the US market for generic opioids as addiction and overdose rates spiked across the nation. According to DEA records, the company provided nearly 40% of all opioid pills sold in US pharmacies between 2006-2012.

In 2011, Mallinckrodt came under investigation by the DEA for failing to meet its requirements to track and report suspicious orders of controlled substances. The company was a defendant in thousands of lawsuits filed by state and local governments, Native American tribes, and individuals against the opioid industry. The plaintiffs accused the company of contributing to the deadly opioid crisis by trivializing addiction and failing to identify and report suspicious drug orders.

In October 2020, Mallinckrodt filed for bankruptcy in Delaware. A court-sanctioned agreement led to the release of 1.4 million documents produced by the company in the litigation (In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020).


Documents include: Email communications between sales representatives, physicians and other healthcare representatives; internal sales training materials, sales rep data, and compensation strategies; submissions to regulatory agencies regarding consumer guides, brochures, and prescribing information; graphics designs for product packaging and labeling; brochures and prescribing publications intended for physicians and the general public; advertisements and marketing materials; correspondence with physicians; and other internal documents.

Documents were redacted for PII and PHI by Mallinckrodt’s legal team. The Opioid Industry Documents Archive contracted with a legal review company to review a sample of the documents to verify appropriate redaction of PII and PHI.

Where to Start...

Mallinckrodt Depositions
Mallinckrodt Key Actors
Mallinckrodt Email Tracker
Mallinckrodt Sales Visit Data

Key Legal Documents

Bankruptcy case background and case docket
Document release agreement and Mallinckrodt request to pause litigation cases
Search terms used to produce documents in the multidistrict litigation between Jan. 1,1998, and Dec. 31, 2017

Notable Mallinckrodt Documents and Related Topics

Efforts to Undermine Health Insurance Restrictions
Pushing Sales to the Limit
Targeting High-Volume Prescribers
Mallinckrodt Speakers’ Program
Lobbying Against Regulation
Responding to Illegal Activity
Collecting Data on Downstream Sales
Creating Playbooks, Targeting Prescribers
Using Food to Gain Access to Prescribers
Other Lines of Inquiry

Related Resources

See our annotated bibliography for more resources providing context of the Mallinckrodt litigation.